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Abstract
Purpose: To understand if clinicians can tell apart patients with healthcare-associated infections (HCAI) from those with
community-acquired infections (CAI) and to determine the impact of HCAI in the adequacy of initial antibiotic therapy and
hospital mortality.
Methods: One-year prospective cohort study including all consecutive infected patients admitted to a large university
tertiary care hospital.
Results: A total of 1035 patients were included in this study. There were 718 patients admitted from the community: 225
(31%) with HCAI and 493 (69%) with CAI. Total microbiologic documentation rate of infection was 68% (n = 703): 56% in CAI,
73% in HCAI and 83% in hospital-acquired infections (HAI). Antibiotic therapy was inadequate in 27% of patients with HCAI
vs. 14% of patients with CAI (p,0.001). Among patients with HCAI, 47% received antibiotic therapy in accordance with
international recommendations for treatment of CAI. Antibiotic therapy was inadequate in 36% of patients with HCAI whose
treatment followed international recommendations for CAI vs. 19% in the group of HCAI patients whose treatment did not
follow these guidelines (p = 0.014). Variables independently associated with inadequate antibiotic therapy were: decreased
functional capacity (adjusted OR= 2.24), HCAI (adjusted OR= 2.09) and HAI (adjusted OR= 2.24). Variables independently
associated with higher hospital mortality were: age (adjusted OR= 1.05, per year), severe sepsis (adjusted OR= 1.92), septic
shock (adjusted OR= 8.13) and inadequate antibiotic therapy (adjusted OR= 1.99).
Conclusions: HCAI was associated with an increased rate of inadequate antibiotic therapy but not with a significant increase
in hospital mortality. Clinicians need to be aware of healthcare-associated infections among the group of infected patients
arriving from the community since the existing guidelines regarding antibiotic therapy do not apply to this group and they
will otherwise receive inadequate antibiotic therapy which will have a negative impact on hospital outcome.
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Introduction
According to the 2012 World Health Organization report,
infections are among the top three leading causes of death
worldwide [1], with community-acquired infections playing a
major role.
At the end of the XXth century, there was a significant increase
in the healthcare service provided in the outpatient setting. As a
consequence, the debate about the need to add a third category
named ‘‘healthcare-associated infections’’ [2–4] to the existing
dichotomy classification of community- and hospital-acquired
infections, arose.
The classification of healthcare-associated infection proposed by
Deborah Friedman in 2002 [2], is one of the most widely used in
clinical studies. According to her, it is an infection present at the
time of hospital admission or within 48 hours of admission, in
patients who fulfill any of the following criteria:
– Received intravenous therapy at home, wound care or
specialized nursing care through a healthcare agency, family
or friends; or, self-administered intravenous medical therapy in
the 30 day period before the onset of the infection. Patients
whose only home therapy was oxygen use are excluded.
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– Attended a hospital or haemodialysis clinic, or having received
intravenous chemotherapy in the previous 30 days.
– Were hospitalized in an acute care hospital for 2 or more days
in the previous 90 days.
– Resided in a nursing home or long-term care facility.
Since then, several studies have shown that the microbiologic
profiles of healthcare-associated infections differ from those of
community-acquired infections [2–4], and that this needs to be
taken into account when prescribing first intention antibiotic
therapy.If healthcare-associated infection are not recognized as a
separate group among infected patients from the community, it
might lead to inadequate first intention antibiotic therapy and
worsen the prognosis.
The objectives of this study are: to understand if doctors
differentiate between patients with healthcare-associated infections
and those with community-acquired infections and to determine
the impact of healthcare-associated infection in the adequacy of
initial antibiotic therapy and hospital mortality.
Methods
Ethics Statement
This study was approved by the Institutional Review Board of
Hospital de Santo Anto´nio, Oporto Hospital Centre, Portugal,
and informed consent was waived due to the observational nature
of the study.
Study Design and Patient Population
A prospective cohort study was conducted in a 600-bed tertiary
care university hospital over the period of 1 year (1st June 2008 to
31th May 2009). All adult infected patients who were admitted to
the medical, surgical, nephrology or hematology wards of the
hospital or to the intensive care unit (ICU), whose infection
fulfilled the CDC criteria [5], were included. Infections were
classified as community-acquired infections (CAI), healthcare-
associated infections (HCAI) or hospital-acquired (HAI), according
to the place of acquisition.
Definitions
Community-acquired infections (CAI) were defined as
infections detected within 48 hours of hospital admission in
patients who did not fit the criteria for a HCAI.
Healthcare-associated infections (HCAI) were defined by
the same criteria that Deborah Friedman used for HCAI
bloodstream infections [2], regardless of the involved focus of
infection. This choice was based on the fact that this definition is
widely used in similar studies and is not limited to bloodstream
infections, but can also be applied to respiratory and specific
pathogene infections [6–11].
Hospital-acquired infections (HAI) were defined as a
localized or systemic condition that resulted from an adverse
reaction to the presence of an infectious agent(s) or its toxin(s), that
occurred within 48 hours or more after hospital admission and
that was not incubating at the time of admission [12]. Infections in
patients discharged from the hospital within the previous 2-week
period were also included in this group.
The comorbidities of patients in the study included immuno-
suppression (administration of chemotherapy in the 12 months
prior to hospital admission, either radiation therapy or adminis-
tration of 0.2 mg/kg/day prednisolone for at least 3 months prior
to hospital admission, administration of 1 mg/kg/day of prednis-
olone for 1 week in the 3 months prior to hospital admission or
infection with human immunodeficiency virus), chronic liver
diseases [13], chronic heart failure [13], chronic respiratory
diseases [13], haematological diseases [14], cancer [14], diabetes
mellitus requiring insulin therapy or oral hypoglycaemic agents
before the infection and/or atherosclerosis (defined as a previous
history of a transient ischemic attack, stroke, angina, myocardial
infarction or peripheral arterial disease).
Table 1. Demographic and clinical characteristics of patients; comparing patients with healthcare-associated infections with
patients with community or hospital-acquired infections.
Patients’ characteristics TOTAL HCAI CAI HAI HCAI vs CAI HCAI vs HAI
(n=1035) (n=225) (n =493) (n =317) p value p value
Age, mean (SD) 65 (20) 68 (19) 64 (20) 64 (19) 0.015# 0.022#
Male sex, n (%) 506 (49) 108 (48) 236 (48) 162 (51) 0.974* 0.476*
Severity of infection, n (%) 0.117* 0.243*
Infection 281 (27) 69 (31) 126 (26) 86 (27)
Sepsis 364 (35) 73 (32) 178 (36) 113 (36)
Severe sepsis 296 (29) 70 (31) 139 (28) 87 (27)
Septic shock 94 (9) 13 (6) 50 (10) 31 (10)
Previous comorbidities, n (%) 671 (65) 190 (84) 270 (55) 211 (67) ,0.001* ,0.001*
Karnofsky index,70, (%) 319 (31) 112 (50) 115 (23) 106 (33) ,0.001* ,0.001*
Hospitalization in the previous year
(excluding the last 3 months, n (%)
413 (40) 55 (43) 91 (19) 174 (55) ,0.001* 0.027*
Previous antibiotic therapy, n (%) 367 (36) 86 (38) 51 (10) 230 (73) ,0.001* ,0.001*
Inadequate antibiotic therapy, n (%) 148 (21) 45 (27) 37 (14) 66 (25) ,0.001* 0.601*
Hospital mortality, n (%) 138 (13) 32 (14) 47 (10) 59 (19) 0.063* 0.178*
CAI – community-acquired infection, HCAI – healthcare-associated infection, HAI – hospital acquired infection, SD – Standard deviation. *Pearson Qui-square Test; # T-
student test.
doi:10.1371/journal.pone.0058418.t001
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The general medical condition was assessed by the Karnofsky
index [15]. A score of less than 70 implies that the patient is unable
to perform normal activities or do active work.
‘‘Hospitalization in the previous year’’ excluded patients already
included in the group of patients with HCAI; that is, those with
hospital admissions in the previous 3 months.
Sepsis and sepsis-related conditions were diagnosed according
to the criteria proposed by the ACCP/SCCM [16].
The initial empirical antibiotic treatment was considered
‘‘adequate’’ if the antibiotic prescribed within the first 24 hours
matched in vitro susceptibility of a pathogen deemed to be the
likely cause of infection and when the dosage and route of
administration were appropriate for current medical status (focus
and severity of infection); only patients in which the pathogen was
microbiologically identified were considered in this analysis.
To evaluate if doctors treated healthcare-associated infections as
community-acquired infections, accordance of initial antibiotic
therapy to the Infectious Diseases Society of America (IDSA)
international recommendations for the treatment of community-
acquired respiratory, urinary and intra-abdominal infections was
assessed [17–19].
Statistical Analysis
Continuous variables are described as means and standard
deviations (SD). Categorical variables are described with absolute
frequencies and percentages. Student T-tests or Mann-Whitney
tests were used to compare continuous values. For categorical
variables these comparisons were performed using Pearson x2 test.
Variables associated with inadequate antibiotic therapy and
hospital mortality were studied using logistic regression. Those
with a clear association in the univariate analysis (p-value ,0.1)
Table 2. Variables associated with inadequate antibiotic therapy using logistic regression.
Variables Total
Inadequate antibiotic
therapy Crude OR CI95% p- value
n=703 n=148
Age, mean (SD) 65 (19) 69 (17) 1.02* 1.001–1.03- 0.063
Sex, n (%)
Female 363 (52) 75 (51) 1.00
Male 340 (48) 73 (49) 1.05 0.73–1.51 0.793
Previous antibiotic therapy, n (%)
No 414 (59) 74 (50) 1.00
Yes 289 (41) 74 (50) 1.58 1.10–2.28 0.014
Hospitalization in the previous year (excluding the last 3
months), n (%)
No 389 (62) 64 (50) 1.00
Yes 241 (38) 64 (50) 1.83 1.24–2.72 0.001
Comorbidities, n (%)
No 222 (32) 38 (26) 1.00
Yes 481 (68) 110 (74) 1.44 0.95–2.16 0.083
Immunosupression, n (%)
No 529 (75) 115 (78) 1.00
Yes 174 (25) 33 (22) 0.84 0.55–1.30 0.437
Chronic hepatic disease, n (%)
No 686 (98) 143 (97) 1.00
Yes 17 (2) 5 (3) 1.58 0.55–4.56 0.396
Chronic heart failure, n (%)
No 653 (93) 134 (90) 1.00
Yes 50 (7) 14 (10) 1.51 0.79–2.87 0.214
Chronic respiratory disease, n (%)
No 661 (94) 41 (95) 1.00
Yes 42 (6) 7 (5) 0.748 0.32–1.70 0.474
Chronic haematologic disease, n (%)
No 652 (93) 135 (91) 1.00
Yes 51 (7) 13 (9) 1.31 0.70–2.53 0.421
Cancer, n (%)
No 670 (95) 136 (92) 1.00
Yes 33 (5) 12 (8) 2.24 1.08–4.67 0.031
*Increase in OR per year; SD – standard deviation, OR – Odds ratio; CI95% - 95% confidence interval.
doi:10.1371/journal.pone.0058418.t002
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were selected for the multivariable analysis. The results of the
multivariable models are expressed as odds ratio (OR) with 95%
confidence interval (CI95%) and p-values. The calibration was
tested using the Hosmer-Lemeshow goodness-of-fit test. The
significance level was defined as p,0.05.
Data was analyzed using SPSS, version 18 for Windows
(Chicago, IL).
Results
During the study period, a total of 3733 patients were admitted
to the selected wards (103 beds); 1035 (28%) met the inclusion
criteria of infections according to the CDC definitions of infection.
Of all patients included, 493 (48%) were diagnosed with CAI,
225 (22%) with HCAI and 317 (30%) with HAI.
Patients with HCAI were older, with a higher prevalence of
previous comorbidities and inability to perform normal activities
or do active work (Karnofsky index,70) than patients in the other
two groups (p,0.05). They also had higher rate of admissions to
hospital in the period between 3 and 12 months prior to the
current episode, as well as previous antibiotic administration and
inadequate antibiotic therapy, when compared to patients with
CAI (p,0.001) (Table 1).
Total rate of microbiological documentation of infection was
68% (n= 703): 73% (n= 165) among patients with HCAI, 56%
(n= 274) among those with CAI and 83% (n= 264) in the group
with HAI.
The empirical antibiotic therapy was changed in 92 patients
(13%) among those with microbiological documentation of
infection (n= 703). The main reason for changing antibiotic
therapy was adjustment to microbiology findings: 81% (n= 26) in
HCAI vs 83% (n= 20) in CAI vs 89% (n= 32) in HAI. Other
reasons for changing antibiotic therapy were a lack of clinical
response in 11% (n= 10), side effects in 3% (n= 3) and others in
1% (n= 1).
In HCAI, 27% had received inadequate antibiotic therapy vs.
14% in CAI (p,0.001). Among patients with microbiologic
documented HCAI, 47% (77) received antibiotic therapy accord-
ing to international recommendations for CAI. Antibiotic therapy
was inadequate in 36% of HCAI patients whose treatment
followed the international recommendations for CAI vs. 19% in
the group of HCAI patients whose treatment did not follow CAI
treatment guidelines (p = 0.014).
The rate of inadequate antibiotic therapy among the four
categories of HCAI was:
– 33% in the group of patients that received intravenous therapy
at home, wound care or specialized nursing care through a
healthcare agency, family or friends; or, self-administered
intravenous medical therapy in the 30 day period before the
onset of the infection;
Table 3. Variables associated with inadequate antibiotic therapy using logistic regression.
Variables Total
Inadequate antibiotic
therapy Crude OR CI95% p- value
n=703 n=148
Diabetes, n (%)
No 558 (79) 119 (80) 1.00
Yes 145 (21) 29 (20) 0.92 0.59–1.45 0.727
Atherosclerosis, n (%)
No 539 (77) 101 (68) 1.00
Yes 162 (23) 47 (32) 1.74 1.17–2.60 0.007
Karnovsky index,70, n (%)
No 479 (68) 80 (54) 1.00
Yes 224 (32) 68 (46) 2.17 1.50–3.16 ,0.001
Type of infection
Community-acquired, n (%) 274 (39) 37 (25) 1.00
Healthcare-associated, n (%) 165 (23) 45 (30) 2.40 1.48–3.91 ,0.001
Hospital-acquired, n (%) 264 (38) 66 (45) 2.14 1.37–3.33 0.001
Focus of infection
Respiratory, n (%) 215 (31) 44 (30) 1.00
Urinary, n (%) 306 (43) 69 (47) 1.13 0.74–1.73 0.570
Intra-abdominal, n (%) 124 (18) 24 (169) 0.93 0.55–1.63 0.806
Other, n (%) 58 (8) 11 (7) 0.91 0.44–1.90 0.801
Severity of infection
Infection, n (%) 191 (27) 41 (28) 1.00
Sepsis, n (%) 238 (34) 53 (36) 1.05 0.66–1.66 0.842
Severe sepsis, n (%) 209 (30) 43 (29) 0.95 0.59–1.53 0.827
Septic shock, n (%) 65 (9) 11 (7) 0.75 0.36–1.55 0.433
OR – Odds ratio; CI95% - 95% confidence interval.
doi:10.1371/journal.pone.0058418.t003
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– 21% in the group of patients that attended a hospital or
hemodialysis clinic, or received intravenous chemotherapy in
the previous 30 days;
– 30% in the group that were hospitalized in an acute care
hospital for 2 or more days in the previous 90 days and
– 36% in those that resided in a nursing home or long-term care
facility.
Variables significantly and independently associated with
inadequate antibiotic therapy were Karnofsky index,70 [adjusted
OR=2.24 (CI95%=1.47–4.41)], HCAI [adjusted OR=2.09
(CI95%= 1.15–3.80)] and HAI [adjusted OR=2.24
(CI95%= 1.41–3.55)] (Tables 2 and 3).
Variables significantly and independently associated with higher
hospital mortality were age [adjusted OR=1.05 (CI95%= 1.03–
1.07), per year], severe sepsis [adjusted OR=1.92 (CI95%= 1.01–
3.63)], septic shock [adjusted OR=8.13 (CI95%= 3.84–17.23)]
and inadequate antibiotic therapy [adjusted OR=1.99
(CI95%= 1.20–3.30)] (Table 4).
The Hosmer and Lemeshow test did not show evidence of lack
of fit in both models (p.0.1).
Discussion
The results of this study show that doctors treat a high
proportion (47%) of patients with healthcare-associated infections
according to community-acquired infections treatment recom-
mendations, implying that they do not differentiate this sub-group
of patients among those with community-acquired infections.
Patients with healthcare-associated infections who were treated
according to the international recommendations for community-
acquired infections had a higher rate of inadequate antibiotic
therapy than those in whom CAI treatment recommendations
were not followed. Healthcare-associated infections were indepen-
dently associated with inadequate antibiotic therapy. Inadequate
antibiotic therapy was an independent risk factor for increased
hospital mortality.
Decision making regarding antibiotic treatment is unique, no
treatment equals its efficacy. In the meta-analysis on the efficacy of
adequate antibiotic therapy for sepsis, by Paul et al [20], the
pooled OR for all-cause mortality was 1.6, corresponding to a
number needed to treat (NNT) of 10 to save one life, higher than
aspirin in acute myocardial infarction (NNT=41), reinforcing the
need to get initial antibiotic therapy adequate in severe infection.
The adequate treatment of healthcare-associated infections is
primarily dependent on the correct classification in patients that
come from the community as CAI or HCAI. Previous studies [2–
4] have shown that patients with HCAI have different microbi-
ological profiles than those with CAI, namely a higher rate of
multi-drug resistant pathogens [21], suggesting that the existing
guidelines for CAI might not be applicable. Clinicians need to be
aware of this difference in order to adapt empiric antibiotic
therapy for HCAI patients.
There are a large number of epidemiological studies on
healthcare-associated infections [3,4,6,7,9,21–23] but the existing
Table 4. Variables associated with hospital mortality using logistic regression.
Variables
Hospital
mortality Crude OR CI95% p- value Adjusted OR CI95%
Age, mean (SD) 76 (14) 1.04* 1.03–1.06 ,0.001 1.05* 1.03–1.07
Sex, n (%) 0.036
Female 59 (43) 1.00
Male 79 (57) 1.47 1.03–2.12
Previously healthy, n (%) ,0.001
Yes 30 (22) 1.00
No 108 (78) 2.14 1.39–3.27
Type of infection
Community-acquired, n (%) 47 (34) 1.00
Healthcare-associated, n (%) 32 (23) 1.57 0.97–2.54 0.064
Hospital-acquired, n (%) 59 (43) 2.17 1.44–3.28 ,0.001
Focus of infection
Respiratory, n (%) 63 (4615) 1.00
Urinary, n (%) 35 (2510) 0.64 0.41–0.99 0.047
Intra-abdominal, n (%) 29 (2114) 0.89 0.55–1.43 0.632
Other, n (%) 11 (819) 0.18 0.64–2.63 ,0.001
Severity of infection
Infection, n (%) 20 (157) 1.00
Sepsis, n (%) 30 (228) 1.17 0.65–2.11 0.597 0.980 0.50–1.92
Severe sepsis, n (%) 46 (3316) 2.40 1.38–4.17 0.002 1.919 1.014–3.632
Septic shock, n (%) 42 (3045) 10.54 5.73–19.40 ,0.001 8.133 3.839–17.231
Inadequate antibiotic therapy,
n (%)
32 (32) 2.01 1.26–3.21 0.003 1.991 1.204–3.295
*Increase in OR per year; OR – Odds ratio, CI95% - 95% confidence interval.
doi:10.1371/journal.pone.0058418.t004
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evidence needs to be systematized, in order to make information
more profitable. Respiratory infections are the ones most widely
addressed and the American Thoracic Society has already
published specific recommendations for healthcare-associated
pneumonia [24]; nevertheless, the wide-spectrum antibiotic
therapy proposed for these patients has turned into a much
debated subject where there is no consensus among clinicians.
Additional studies are needed in this area, with thorough
microbiologic characterization from different settings, before
specific recommendations regarding empirical treatment for
different focus of HCAI can be made.
HCAI was not found to be an independent risk factor for
hospital mortality although the association of HCAI and higher
mortality was described in the studies by Kollef et al [3] and Shorr
et al [4]. However, none of them perform a multiple logistic
regression to allow the statement of HCAI as an independent risk
factor, as it was done in the present study.
There are several studies describing the negative impact of
initial inadequate antibiotic therapy on mortality [25–32]. The
results of the present study are in accordance with previous
findings, from different centres and geographical areas, increasing
the probability of wide external applicability of the main results.
Major strengths of this study are its prospective design with
thorough data collection, the use of clear definitions in the
protocol, data collection by a single trained doctor and full
completion of all protocols with no missing data per item
minimizing any information bias. Additionally, all patients
completed the follow-up until hospital discharge. The similarity
of some results with previous studies suggests an increased external
application of the conclusions.
There are also some limitations that should be pointed out. The
research was performed in a single institution and the number of
patients with HCAI was relatively low. Only 68% of the patients
had microbiologic documentation of infection and were evaluated
for the adequacy of empirical antibiotic therapy; this may limit the
logistic regression analysis in terms of its ability to detect all
independent variables associated with inadequate antibiotic
therapy and outcome. Nevertheless, the variables found were
clinically significant and relevant, easily recognizable, and could
function as additional aids to avoid inadequate therapy.
Conclusions
HCAI were associated with an increased rate of inadequate
antibiotic therapy, but not with a significant increase in hospital
mortality.
Clinicians need to be aware of healthcare-associated infections
among the group of infected patients arriving from the commu-
nity, as the existing guidelines regarding antibiotic therapy do not
apply to them. This is essential in order to prevent the associated
inadequate antibiotic therapy and its negative impact on hospital
outcome.
The development of specific guidelines for this group of infected
patients should be considered.
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